Hrt Financial LP Imara Inc. Transaction History

Hrt Financial LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.11 - $2.42 $17,529 - $38,216	15,792 New	15,792 $36,000
Q4 2021 Feb 14, 2022	SELL	$2.25 - $4.05 $52,197 - $93,955	-23,199 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$4.08 - $7.83 $5,238 - $10,053	1,284 Added 5.86%	23,199 $94,000
Q2 2021 Aug 16, 2021	BUY	$6.78 - $9.04 $148,583 - $198,111	21,915 New	21,915 $173,000

104K

170K

Ticker IMRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,287,300
Market Cap $552M
Description
IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develop...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.